Affirm Holdings (AFRM) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.Over the past month, shares of this operator of digital commerce platform have returned +16.1%, compared to the Zacks S&P 500 composite's +3.9% change. During this period, the Zacks Internet - Software industry, which Affirm Holdings falls in, has gained 2.7%. The key question now is: What could be the stock's futur ...

Textron Inc. (NYSE: TXT ) demonstrates stability in the defense segment and stable cash generation, but continues to face restrictions in civilian areas. At current multiples, the company is trading at a significant discount toHey, I’m Gevork Avtandilov. I work as a private banker, and I’ve been in finance for 13 years now — started pretty young. Got my degrees in Economics and Management back in Italy, and that’s where I kicked off my career too. Since then, I’ve been working closely with wealthy clients, ...

POLAND - 2025/02/22: In this photo illustration, the Jazz Pharmaceuticals company logo is seen ... More displayed on a smartphone screen. (Photo Illustration by Piotr Swat/SOPA Images/LightRocket via Getty Images)SOPA Images/LightRocket via Getty ImagesJazz Pharmaceuticals (NASDAQ: JAZZ) is currently trading at approximately $110, having decreased by 11% year-to-date, even after a significant positive development with the conditional European Commission Marketing Authorization for Ziihera (zanidatamab) aime ...

BJ's Wholesale Club TodayBJBJ's Wholesale Club$108.25 -0.89 (-0.82%) 52-Week Range$76.33▼$121.10P/E Ratio25.17Price Target$116.12Add to WatchlistThe hefty valuation bestowed on Costco Wholesale Corp. NASDAQ: COST may have finally caused the bulk retailer’s stock to spring a leak. The stock trades at a premium that has long spooked more value-conscious investors, but has continued to produce strong earnings and membership growth returns. Now that cracks are beginning to show despite U.S. stocks returning to ...

Core Viewpoint - Sea Limited has made a significant recovery after a challenging 2022, returning to profitability and showing renewed momentum across its e-commerce, gaming, and fintech segments, although competition is intensifying in the Southeast Asian market [1][2]. Group 1: Business Performance - Sea Limited has regained profitability and improved cost discipline, leading to a more than 100% increase in stock price from its lows [2]. - The fintech segment, rebranded as Monee, has become a strong profit contributor with over 28 million active borrowers and a loan book of $5.8 billion, reflecting a growing demand for credit products [10]. - Monee generated $787 million in revenue in the first quarter, a 58% year-over-year increase, with adjusted EBITDA reaching $241 million, up 62% year-over-year [11]. Group 2: Competitive Landscape - Shopee, Sea's e-commerce platform, holds over 50% market share in several Southeast Asian countries but faces increasing competition from TikTok Shop, Lazada, and other regional players [4][5][6]. - TikTok Shop is rapidly gaining traction, particularly among Gen Z users, creating new shopping behaviors that Shopee does not fully replicate [5]. - Lazada, backed by Alibaba, is leveraging its resources in logistics and technology to regain market share, posing a serious threat to Shopee [6]. Group 3: Risks and Challenges - The competitive landscape is becoming more challenging, with Shopee needing to reinvest in logistics and promotions, which could pressure short-term margins [9]. - Monee's rapid growth in lending exposes it to potential risks, particularly as it serves first-time borrowers who may lack formal credit histories [12]. - Regulatory changes in digital lending across Southeast Asia could slow growth or increase compliance costs, similar to past events in China [13]. Group 4: Valuation and Market Sentiment - Sea Limited's stock has rebounded to nearly $150, moving away from its "deep value" phase, with current price-to-sales and price-to-earnings ratios at 5.3 and 106, respectively [14]. - The market is no longer pricing Sea as a broken growth story, indicating that any negative developments could lead to a significant stock price correction [15]. - Investors need to be cautious as the company faces competitive threats, credit exposure, and potential volatility in stock prices [16].

Core Viewpoint - Johnson & Johnson is currently under observation due to its stock performance and potential future direction, particularly in relation to earnings estimates and revenue growth [1][2]. Earnings Estimate Revisions - For the current quarter, Johnson & Johnson is expected to report earnings of $2.64 per share, reflecting a decrease of -6.4% year-over-year, with a slight increase of +0.5% in the Zacks Consensus Estimate over the last 30 days [5]. - The consensus earnings estimate for the current fiscal year is $10.62, indicating a growth of +6.4% from the previous year, with a minor adjustment of +0.1% in the last month [5]. - For the next fiscal year, the earnings estimate stands at $11, suggesting a growth of +3.6% compared to the prior year, with a recent increase of +0.2% [6]. - Johnson & Johnson holds a Zacks Rank 2 (Buy), indicating a favorable outlook based on earnings estimate revisions [7]. Revenue Growth Forecast - The consensus sales estimate for the current quarter is $22.77 billion, representing a year-over-year increase of +1.4% [11]. - For the current fiscal year, the revenue estimates are $91.19 billion and $94.24 billion, indicating growth rates of +2.7% and +3.4%, respectively [11]. Last Reported Results and Surprise History - In the last reported quarter, Johnson & Johnson achieved revenues of $21.89 billion, a year-over-year increase of +2.4%, and an EPS of $2.77, up from $2.71 a year ago [12]. - The company exceeded the Zacks Consensus Estimate for revenues by +1.26% and for EPS by +7.78% [12]. - Johnson & Johnson has consistently beaten consensus EPS and revenue estimates over the past four quarters [13]. Valuation - Johnson & Johnson is graded B in the Zacks Value Style Score, indicating it is trading at a discount compared to its peers [17].

CHONGQING, CHINA - MAY 04: In this photo illustration, the logo of Oscar Health, Inc. is displayed ... More on a smartphone screen, with the company's branding visible in the background, on May 04, 2025, in Chongqing, China. (Photo illustration by Cheng Xin/Getty Images)Getty Images On July 2nd, the health insurance sector underwent a notable decline following Centene (NYSE:CNC)'s retraction of its financial outlook, citing rising costs. Refer to – Centene: Is The Recent Decline In CNC Stock Justified? This ...

Bouncing back from a disappointing performance in May, shares of rare earths producer MP Materials (MP 2.79%) raced considerably higher last month. According to data provided by S&P Global Market Intelligence, MP Materials stock rose 52.7% in June.In addition to the ongoing trade dispute with China -- of which rare earths are a focus -- positive commentary from analysts contributed to the stock's rise. News from both Washington and Wall Street wound up investors' excitement last monthEarly in the month, the ...

Novavax (NVAX) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near future. Over the past month, shares of this vaccine maker have returned -10.9%, compared to the Zacks S&P 500 composite's +5.2% change. During this period, the Zacks Medical - Biomedical and Genetics industry, which Novavax falls in, has gained 0.9%. The key question now is: What could be the stock's future di ...

Core Viewpoint - Momentum investing focuses on "buying high and selling higher" rather than traditional strategies of "buying low and selling high" [1] Group 1: Momentum Investing Strategy - Momentum investors often face challenges in determining the right entry point for fast-moving stocks, which can lead to limited upside or potential losses [2] - A safer approach involves investing in bargain stocks that exhibit recent price momentum, utilizing tools like the Zacks Momentum Style Score to identify suitable candidates [3] Group 2: Telesat (TSAT) Analysis - Telesat (TSAT) has shown significant recent price momentum with a four-week price change of 54.1%, indicating growing investor interest [4] - Over the past 12 weeks, TSAT's stock has gained 41.9%, demonstrating its ability to deliver positive returns over a longer timeframe [5] - TSAT has a beta of 2.1, suggesting it moves 110% higher than the market in either direction, indicating fast-paced momentum [5] - The stock has a Momentum Score of B, suggesting it is an opportune time to invest [6] - TSAT has received a Zacks Rank 2 (Buy) due to upward trends in earnings estimate revisions, which typically attract more investor interest [7] - The stock is trading at a Price-to-Sales ratio of 0.86, indicating it is reasonably valued at 86 cents for each dollar of sales [7] Group 3: Additional Investment Opportunities - Besides TSAT, there are other stocks that meet the criteria of the 'Fast-Paced Momentum at a Bargain' screen, presenting further investment opportunities [8] - Investors can explore over 45 Zacks Premium Screens tailored to different investing styles to identify potential winning stocks [9]